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A very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of
asymptomatic human individuals infected with Plasmodium vivax. The mechanisms under-
lying this intense tropism are not clear. We hypothesised that immature reticulocytes, in
which P. vivax develops, may display high densities in the spleen, thereby providing a niche
for parasite survival.
Methods and findings
We examined spleen tissue in 22 mostly untreated individuals naturally exposed to P. vivax
and Plasmodium falciparum undergoing splenectomy for any clinical indication in malaria-
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endemic Papua, Indonesia (2015 to 2017). Infection, parasite and immature reticulocyte
density, and splenic distribution were analysed by optical microscopy, flow cytometry, and
molecular assays. Nine non-endemic control spleens from individuals undergoing spleno-
pancreatectomy in France (2017 to 2020) were also examined for reticulocyte densities.
There were no exclusion criteria or sample size considerations in both patient cohorts for
this demanding approach.
In Indonesia, 95.5% (21/22) of splenectomy patients had asymptomatic splenic Plasmo-
dium infection (7 P. vivax, 13 P. falciparum, and 1 mixed infection). Significant splenic accu-
mulation of immature CD71 intermediate- and high-expressing reticulocytes was seen, with
concentrations 11 times greater than in peripheral blood. Accordingly, in France, reticulo-
cyte concentrations in the splenic effluent were higher than in peripheral blood. Greater
rigidity of reticulocytes in splenic than in peripheral blood, and their higher densities in
splenic cords both suggest a mechanical retention process. Asexual-stage P. vivax-infected
erythrocytes of all developmental stages accumulated in the spleen, with non-phagocytosed
parasite densities 3,590 times (IQR: 2,600 to 4,130) higher than in circulating blood, and
median total splenic parasite loads 81 (IQR: 14 to 205) times greater, accounting for 98.7%
(IQR: 95.1% to 98.9%) of the estimated total-body P. vivax biomass. More reticulocytes
were in contact with sinus lumen endothelial cells in P. vivax- than in P. falciparum-infected
spleens. Histological analyses revealed 96% of P. vivax rings/trophozoites and 46% of
schizonts colocalised with 92% of immature reticulocytes in the cords and sinus lumens of
the red pulp. Larger splenic cohort studies and similar investigations in untreated symptom-
atic malaria are warranted.
Conclusions
Immature CD71+ reticulocytes and splenic P. vivax-infected erythrocytes of all asexual
stages accumulate in the same splenic compartments, suggesting the existence of a cryptic
endosplenic lifecycle in chronic P. vivax infection. Findings provide insight into P. vivax-spe-
cific adaptions that have evolved to maximise survival and replication in the spleen.
Author summary
Why was this study done?
• There is a surprisingly large biomass of intact Plasmodium vivax parasites in the spleen
of people living in malaria endemic areas, greater than with Plasmodium falciparum.
• Why P. vivax accumulates so intensely in the spleen is not known.
• P. vivax requires very young red cells (immature reticulocytes) for invasion and
replication.
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What did the researchers do and find?
• The accumulation of P. vivax and immature reticulocytes were evaluated in spleens
from people undergoing splenectomy in malaria-endemic Papua.
• P. vivax parasites and immature reticulocytes accumulated in the same splenic
compartments.
• All stages of P. vivax accumulated in the spleen at magnitudes unexplainable by replica-
tion occurring in the circulation alone, with the proportion of each stage in the spleen
consistent with the duration in their lifecycle.
What do these findings mean?
• Taking advantage of the large physiological splenic reservoir of immature reticulocytes,
the majority of the P. vivax lifecycle can take place in the spleen in chronic malaria.
• Chronic vivax malaria should be considered predominantly an infection of the reticulo-
cyte-rich spleen, with secondary involvement of the intravascular compartment.
• The spleen is not solely a compartment for parasite destruction and clearance.
• Specific adaptations have likely evolved to maximise P. vivax survival in the spleen.
Introduction
Malaria, mainly due to Plasmodium falciparum (Pf) and Plasmodium vivax (Pv), affects 228
million people with over 400,000 deaths each year [1]. The multistep life cycle of malaria para-
sites in humans involves 2 cell types: hepatocytes and erythrocytes. Initial hepatic tropism is
clinically silent, while subsequent parasite development in erythrocytes almost invariably
causes symptoms in nonimmune individuals and is thought to restrict parasite spread in the
human body almost exclusively to the intravascular compartment.
Despite a growing body of research in Pv over the last 2 decades [2,3], vivax malaria
remains less understood and presents a greater challenge to elimination than its more preva-
lent and virulent Pf counterpart [4]. A key biological feature of Pv not present in Pf is its ability
to cause relapse from dormant stages in the liver. Hospitalisation with severe vivax malaria has
been widely reported [5–11] and can lead to death [12,13], despite Pv displaying lower circu-
lating parasite densities than Pf [14,15]. Lower parasitaemia has been attributed to the strict
tropism of Pv for reticulocytes [16], a population of erythrocyte precursors originating in the
bone marrow and found at low levels in peripheral blood. Such low parasitaemias have long
been considered to indicate a low total parasite biomass in vivax malaria. However, computa-
tional Pv modelling based on Plasmodium cynomolgi growth data [17] and indirect measures
in clinical Pv [18] point to a hidden subpopulation of parasites related to disease severity and
residing in non-endothelial lined compartments [15]. Several reports in clinical Pv have con-
firmed the presence of intact asexual and sexual-stage infected erythrocytes (IEs) in the bone
marrow [19–23] and spleen [23–25].
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The spleen eliminates malaria parasites after antimalarial treatment [26–28] and has been
assumed to be primarily an organ for parasite destruction. However, our recent evaluation of
individuals undergoing splenectomy in malaria-endemic Papua, Indonesia, has found a very
large biomass of intact asexual-stage Pv and Pf-IEs hidden in the spleen in chronic asymptom-
atic infections [29]. Splenic tropism was greater in Pv than Pf [29], but the reason for this is
unclear. Direct evidence to support a cryptic Pv lifecycle in this organ remains lacking. Imma-
ture reticulocytes, characterised by expression of the CD71 transferrin receptor [30], are pref-
erentially invaded by Pv for replication [31,32]. Animal studies [33–37] and a single early
report in humans [38] have described reticulocyte pooling in the spleen. Whether the human
spleen is concentrated with the immature reticulocyte subpopulations preferentially invaded
by Pv has not been investigated.
Here, we extend our findings from the initial cohort with additional patients and experi-
ments to characterise splenic reticulocyte subpopulations, Plasmodium developmental stages,
and their co-compartmentalization in the human spleen, hypothesising the existence of an
endosplenic asexual lifecycle in chronic asymptomatic Pv.
Methods
Splenectomy patients and samples
Setting. Rumah-Sakit-Umum-Daerah (RSUD) is the major regional hospital in the
Mimika District of Papua, Indonesia. In this region, malaria transmission is unstable, with a
blood parasitaemia prevalence of 14% and 38% by microscopy and polymerase chain reaction
(PCR), respectively, and with approximately equal proportions of Pf and Pv infection [39].
Enrolment. The research team was on-call 24 hours a day for any patients undergoing
elective splenectomy or explorative laparotomy for potential spleen rupture at RSUD hospital.
All consenting patients undergoing splenectomy for any clinical indication were enrolled in
the study between 2015 and 2017, as previously reported in brief [29]. There were no exclusion
criteria or sample size considerations for this demanding approach. Demographic and clinical
data were collected, including automated blood counts.
Management. As described previously in brief [29], a locally feasible protocol for the
management of splenectomised patients was implemented based on international guidelines
[40]. Upon recovery, patients were given post-splenectomy meningococcal, pneumococcal,
Haemophilus and influenza vaccinations with Menveo, Prevenar 13, Hiberix, and Influvac.
Local antimalarial treatment consisting of 3 days dihydroartemisinin-piperaquine, plus 14
days primaquine for P. vivax infections [41], was given to patients found to have Plasmodium
infection by blood smear microscopy. Before discharge, patients were tested for human immu-
nodeficiency virus and provided with standby antibiotics (3 g amoxicillin) in case of fever.
Local clinicians and the District Health Authority deemed daily antibiotic prophylaxis unsus-
tainable. Malaria radical cure for all patients undergoing splenectomy was introduced at the
end of the study upon analysis of malaria risk [42].
Sample collection
Day of surgery. The decision to proceed to splenectomy was made by the treating surgeon
on clinical grounds. Eighteen millilitres of peripheral blood was collected intraoperatively into
3 anticoagulants: ethylenediaminetetraacetic acid (EDTA), lithium-heparin, and acid citrate
dextrose (ACD) (BD Biosciences, Australia). Any remaining blood collected preoperatively
that was to be discarded was also collected. All spleen tissue removed at the time of surgery
(intact or in portions) was collected by the research team in the operating theatre. Histopathol-
ogy is not routine at RSUD. Any splenectomy patients that were transfused prior to surgery
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had a sample of donor blood taken from the transfusion bag. Thick and thin blood smears
were prepared from each blood sample and stained with 3% Giemsa solution (Merck, Darm-
stadt, Germany) for 45 minutes at room temperature (RT).
Spleen dissection. The spleen was immediately transferred to the hospital laboratory.
Blood on the surface of the spleen was removed. Images and spleen weight were recorded
(S1A Fig). Using sterile equipment and in a clean work area, the spleen was sliced approxi-
mately in half as shown in S1B Fig and one half set aside to generate formalin-fixed paraffin-
embedded blocks (FFPE). The remaining half was sliced longitudinally into multiple sections
of 0.5 to 1 cm thickness (S1C Fig). Sliced-spleen blood was collected as detailed below. Dam-
aged tissue was avoided in all sample processing. Blood and spleen samples were transferred at
RT to the research laboratory for further experiments.
Sliced-spleen blood collection. Tissue sections of approximately 1 cm3 in size were sam-
pled randomly from spleen slices. Three pieces were added to each of up to eighteen 50 mL fal-
con tubes containing 15 mL of sterile RPMI 1640 medium (Thermofisher, Massachusetts,
United States) supplemented with either EDTA, heparin or ACD (Sigma Aldrich, Missouri,
US). Suspensions were incubated at RT on a slow rotator, or on the bench and inverting every
5 minutes, for up to 90 minutes. Spleen pieces were removed and the suspensions pooled for
each anticoagulant through 70 μm SmartStrainers (Miltenyi Biotec, Bergisch Gladbach, Ger-
many), then centrifuged at 500g for 15 minutes. Supernatants were discarded and the pellets
resuspended in equal volumes of RPMI 1640 medium. The resulting suspensions were termed
sliced-spleen blood with EDTA, heparin, or ACD. Thick and thin blood smears were prepared
for sliced-spleen blood and stained with 3% Giemsa solution for 45 minutes at RT.
Biopsy and blood for molecular assays. Up to fifteen 0.5 cm punch biopsies were col-
lected randomly from spleen slices and snap frozen in liquid nitrogen. EDTA-anticoagulated
peripheral and sliced-spleen blood samples were centrifuged at 600g for 10 minutes. Aliquots
of the resulting packed red blood cell (RBC) pellets were stored at −80˚C.
Formalin-fixed paraffin-embedded blocks. The unused spleen half was sliced longitudi-
nally to 0.5 to 1 cm in thickness and fixed at RT for 48 to 72 hours in 1 L of 10% neutral-buff-
ered formalin (NBF; containing 100 mL 37% to 40% formaldehyde, 900 mL deionised water,
6.5 g Na2HPO4, and 4 g NaH2PO4). NBF was replaced every 24 hours. After fixation, 0.5 cm
punch biopsies were taken randomly from spleen slices and placed into histology cassettes. To
dehydrate the tissue, fixed biopsies were incubated in absolute ethanol for 20 minutes at 60˚C,
then placed in fresh ethanol and incubated again until a total of four 20-minute incubations
were performed. Fixed biopsies were then incubated in pure xylene for 10 minutes at RT,
drained, then submerged in Paraplast Plus (Leica Biosystems, Wetzlar, Germany) for 30 min-
utes at 60˚C. Fixed biopsies were carefully positioned in metal base moulds, filled with Para-
plast Plus, covered with labelled cassettes, and incubated for 15 minutes at −20˚C to solidify.
FFPE were detached from the base moulds and stored at RT until further use.
Total immunoglobulin M (IgM). In patients with massively large spleens, total IgM levels
were measured to confirm or infer the suspected diagnosis of Hyperreactive Malarial Spleno-
megaly (HMS). Frozen plasma from lithium-heparin peripheral blood was used for total IgM
measurement using a BN ProSpec protein analyser (Siemens Healthineers, Erlangen, Ger-
many). Frozen plasma from 54 adults collected in a household survey [39] were used as con-
trols representing baseline IgM levels in the Timika population.
Follow-up. Peripheral blood was collected again from splenectomised patients�2 months
after splenectomy and processed identically. Patients were given meningococcal booster vacci-
nations with Menveo and undertook clinical checkup by a research clinician. Bimonthly inter-
views were conducted for up to 14 months to collect data on post-splenectomy malaria or
PLOS MEDICINE An endosplenic Plasmodium vivax lifecycle in chronic malaria
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003632 May 26, 2021 5 / 35
other illnesses. Reported malaria episodes were confirmed with the treating hospital or health
clinic.
Plasmodium detection and quantification
Rapid Diagnostic Test (RDT) and blood smear microscopy. Peripheral blood was
tested for Plasmodium detection using the First Response Malaria Ag (Plasmodium lactate
dehydrogenase [pLDH]/histidine-rich protein-2 [HRP2]) Combo RDT as per manufactur-
er’s instructions (Premier Medical Corp., Daman, India). Giemsa-stained slides of periph-
eral blood and sliced-spleen blood were examined by 2 expert microscopists for the
presence of Plasmodium-infected erythrocytes as previously described [29] using CX31
LED microscopes (Olympus, Tokyo, Japan). At least 40 thick smear high-power fields
(HPFs) were examined at 1,000× magnification. Peripheral blood parasitaemia and parasite
staging was determined in the thick smear as parasites per 500 white blood cells (WBCs).
Automated WBC counts were used to calculate the number of parasites per μL peripheral
blood. Non-phagocytosed peripheral IEs as a percentage of total circulating RBCs was also
calculated for comparison to non-phagocytosed IEs in the spleen. In the comparisons of
peripheral and splenic non-phagocytosed parasitaemias, individuals with submicroscopic
PCR-positive peripheral parasitaemia were conservatively assigned a parasite count of 10
parasites per μL based on the lower limit of detection by an experienced microscopist (10 to
20 parasites per μL) [43], with PCR-negative peripheral parasitaemia assigned a value of
zero per μL.
Giemsa histopathology was performed as described previously [29] and summarised
below. FFPE were sliced to 5 μm in thickness and placed on poly-L-treated microscope slides.
Slides were deparaffinised in xylene (3 × 5 minutes), then rehydrated in a series of alcohol
baths; absolute ethanol (2 × 5 minutes), 90% ethanol (5 minutes), 70% ethanol (5 minutes),
and water (10 minutes). Slides were stained with 10% Giemsa in water for 30 to 45 minutes at
RT. After rinsing, slides were further stained with 0.5% aqueous acetic acid for 10 to 30 sec-
onds, then rapidly washed in a series of alcohol baths (70%, 90%, and 100% ethanol). Slides
were dipped in 2 xylene baths, followed by incubation in a third clean xylene bath for 10 min-
utes at RT. Coverslips were mounted on to stained slides with Entellan (Merck, Darmstadt,
Germany).
Sections were analysed by an expert microscopist to quantify non-phagocytosed IEs
using an Olympus CX31 microscope. A second expert microscopist validated parasite quan-
titation in 30% of patients, and a third external microscopist qualitatively reviewed 20% of
the panel (S1D Fig). Architectural regions were distinguished into the red-pulp sinus
lumen and cords, and white-pulp perifollicular zones (PFZ) and non-circulatory spaces.
Ten HPFs were examined in each of the red and white-pulp/PFZ areas at 1,000× magnifica-
tion. The area covered by red and white-pulp was quantified using a digital tracing tool to
enable normalisation of HPF counts and estimations of total splenic biomass. Non-phago-
cytosed IE and uninfected RBCs were counted in each region, and parasites categorised into
groups based on their developmental stages (rings/trophozoites, schizonts, gametocytes, or
unclassifiable stages). Parasites in Giemsa stains of this type of tissue appear different to
their traditional colouration and morphology in normal blood smears. Non-phagocytosed
IEs were identified as red/pink RBCs containing at least 1 circular brown dot (parasite
nucleus) with or without light blue parasite cytoplasm visible as previously validated [44].
The need to assess various Z-planes by fine focus was an important step to confirm non-
phagocytosed IEs.
Calculations. The following calculations were performed, as previously reported [29]:
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i. IEs per μL peripheral blood
¼
½IE count per 500 WBC� � ½WBC count per mL from analyser�
500
ii. Non-phagocytosed peripheral IEs as % of peripheral RBCs
¼
IEs per mL peripheral blood
RBC count per mL from analyser
� 100
Individuals with submicroscopic peripheral parasitaemia were conservatively assigned a
parasite count value of 10 parasites per μL based on the lower limit of detection by an expe-
rienced microscopist (10 to 20 parasites per μL) [43].
iii. Non-phagocytosed splenic IEs as % of splenic RBCs
¼
non  phagocytosed IE count
½non  phagocytosed IE count� þ ½RBC count�
� 100
Note: IE and RBC counts were determined in each spleen zone, then normalised according
to the proportion of each zone within a given area.
iv. Non-phagocytosed spleen-to-peripheral parasite density ratio
¼
non  phagocytosed splenic IEs as % of splenic RBCs
non  phagocytosed peripheral IEs as % peripheral RBCs
Note: Individuals that were PCR-negative in peripheral blood were assigned a peripheral
parasite count of zero and therefore were not included in this ratio.
v. Distribution of parasite developmental stages in the spleen
(e.g., for schizonts)
¼
non  phagocytosed schizont IE count
½total non  phagocytosed IE count�
� 1; 000
Note: IE counts were determined in each spleen zone, then normalised according to the
proportion of each zone within a given area.
vi. Total non-phagocytosed parasite biomass in peripheral blood
¼ ½IEs per mL peripheral blood� � ½total peripheral blood volume; see below� � 106
vii. Total peripheral blood volume in litres (Nadler’s method)
male ¼ ½0:3669� ½height in meters�3� þ ½0:03219� ½patient weight in kg�� þ 0:6041
female ¼ ½0:3561� ½height in meters�3� þ ½0:03308� ½patient weight in kg�� þ 0:1833
where the average height of males is 1.58 meters and females is 1.47 meters in Indonesia
[45]. Patient weights were available for a subset of individuals. Those that were missing
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were given a value corresponding to the national average of 59.5 kg for males and 54.8 kg
for females [45].
viii. Total non-phagocytosed parasite biomass in the spleen
¼
½IE count in HPFs� � ½spleen weight�
½spleen volume per HPF in cm3; see below� � ½number of HPFs� � ½density of human spleen in g=cm3�
where density of human spleen = 1.04 g/cm3, from [46].
Note: Biomass was normalised according to the proportion of each zone within a given
area.
ix. Spleen volume (in cm3) per HPF
¼
½area of HPF in mm2� � ½section depth in mm�
1; 000
Where area of HPF is πr2 (r = 100 μm on Olympus CX31 at 1,000× magnification), and
section depth was 0.005 mm.
x. Non-phagocytosed IE biomass in the spleen as a percentage of the total intravascular, bone
marrow, and intrasplenic biomass
¼
total non  phagocytosed IE biomass in the spleen
½total non  phagocytosed IE biomass in the spleen; bone marrow; and peripheral blood�
� 100
Note: Total bone marrow Pv biomass is an estimation based on 2 assumptions. Firstly, we
assumed a bone marrow Pv parasitaemia equal to peripheral blood and consisting of 80%
asexual stages, as observed in a previous study comparing bone marrow aspirates and
peripheral blood from patients with uncomplicated vivax malaria [20]. Secondly, in a 60-kg
person, the bone marrow can be estimated to contain 1.9 × 1011 reticulocytes [47]. Assum-
ing that the bone marrow releases 2.2 × 1011 RBCs per day [48], we conservatively estimate
that at steady-state, there may be up to 4 times this amount present in the bone marrow
consisting of normocytes and young to mature reticulocytes (given commonly reported
maturation times between 1 and 3 days [31,49]), as well as any physiological retention.
Bone marrow biomass
¼
non  phagocytosed peripheral IEs % peripheral RBCs
100
� 4� 2:2� 1011 � 0:8
xi. Non-phagocytosed spleen-to-peripheral biomass ratio
¼
non  phagocytosed IE biomass in the spleen
non  phagocytosed IE biomass in peripheral blood
xii. Non-phagocytosed IEs in each spleen compartment as % of total non-phagocytosed IEs
¼
non  phagocytosed IE count in cords;
sinus lumen;PFZ; or non  circulatory whte pulp spaces
total non  phagocytosed IE count
� 100
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Note: IE counts were determined in each spleen zone, then normalised according to the
proportion of each zone within a given area. The same calculation was performed for each
parasite stage.
xiii. Non-phagocytosed parasitaemia for each stage
(e.g., for schizonts)
¼
non  phagocytosed schizont IE count
½non  phagocytosed IE count� þ ½RBC count�
� 1; 000
Pv-AMA1 and CD68 immunohistochemistry (IHC). Rehydrated FFPE spleen sections
were stained manually with antibodies against Pv apical membrane antigen-1 (PvAMA1) pep-
tide, a marker for Pv merozoites/mature stages, as described previously [29,50]. A dilution of
1:200 was used, and with secondary detection using N-Histofine simple stain MAX PO
(Nichirei Biosciences, Tokyo, Japan). For CD68 IHC, rehydrated spleen sections were stained
with a monoclonal mouse anti-human CD68 (clone KP-1) antibody (Roche, Basel, Switzer-
land) followed by secondary detection with N-Histofine simple stain MAX PO using an auto-
mated Leica BOND-III platform (Leica Biosystems, Wetzlar, Germany). All sections were
counterstained with hematoxylin.
Transmission electron microscopy. Glutaraldehyde (2.5%) in cacodylate buffer was used
to fix spleen tissue, then postfixed with 2% osmium tetroxide and 2.5% potassium ferricyanide
in distilled water. After dehydration in ethanol and infiltration with propylene oxide, tissue
was embedded in spurr resin followed by a vacuum step. Staining of ultrathin 7-nm sections
with 2% uranyl acetate and triple lead citrate was performed, then examined using a JEOL
JEM-1010 electron microscope (Tokyo, Japan) at 80 kv. Images were captured on special nega-
tive films, developed, and scanned.
Ex vivo spleen perfusion. A mixed culture of Pf-IEs (FUP/CB strain) prepared accord-
ingly [51] was perfused through an uninfected control human spleen for 2 hours under physio-
logical flow conditions as published [28,44]. Upon completion, the spleen was fixed by gently
perfusing 70 to 100 mL of 4% formaldehyde and then cut into blocks for further fixation. FFPE
and Giemsa-stained spleen sections were prepared as described for Indonesian spleen samples.
DNA extraction. QIAamp DNA mini kits (QIAGEN, Hidlen, Germany) were used for
extraction of genomic DNA (gDNA) from 2 snap frozen spleen tissue biopsies (8 to 25 mg per
biopsy), peripheral packed RBCs, and sliced-spleen packed RBCs (both approximately 100 μL)
per patient. Exact weights/volumes were recorded for each sample. DNA extraction of periph-
eral blood samples was performed according to the manufacturer’s spin protocol, except that
the final elution was with 100 μL of buffer AE (supplied).
gDNA from spleen biopsies and sliced-spleen blood samples were extracted according to a
modified version of the manufacturer’s tissue purification protocol. Briefly, spleen samples
were incubated at 4˚C overnight in 150 μL of ATL buffer (supplied). An additional 100 μL of
ATL buffer was added and biopsies cut into smaller pieces. Proteinase K (supplied) was used
to disrupt the tissues (30 μL for biopsies and 20 μL for sliced-spleen blood samples) on a slow
shaker at 56˚C for 3 hours. Samples were mixed with 200 μL of ethanol, vortexed, then applied
to the QIAamp Mini spin columns (supplied). The remaining steps were performed according
to the manufacturer’s instructions and the gDNA eluted as per peripheral blood samples.
Extracted gDNA was stored at −20˚C until further use.
Nested PCR. Plasmodium species confirmation and detection of submicroscopic infec-
tions was undertaken in duplicate in 2 separate laboratories using a nested PCR protocol
described elsewhere [52,53]. One microliter gDNA template was used in the first nest, and
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1 μL of the resulting product ran neat and/or diluted 1:20 in water for the second nest. Small
subunit ribosomal RNA DNA clones of Pf, Pv, Plasmodium malariae, and Plasmodium ovale
(MRA-177, MRA-178, MRA-179, and MRA-180; ATCC, Manassas, Virginia) were used as
positive controls. The limit of detection of the assay was 0.2 parasites/μL [54]. Samples were
considered positive for Plasmodium species if results were positive in both laboratories. If
results were discrepant, samples were considered positive if a Plasmodium species was detected
using a third confirmatory assay (real-time PCR). The spleen was considered positive if any of
the spleen biopsies and/or sliced-spleen blood samples were positive for Plasmodium species.
Real-time PCR. A real-time PCR assay was developed for the detection Pf and Pv parasite
DNA in gDNA samples using the QuantStudio-6 Flex Real-Time PCR System (Thermofisher,
Massachusetts, US). Specific primer-probe pairs coupled to different fluorescent reporter dyes
enabled multiple target products to be distinguished in a single reaction. Two microliters of
gDNA template were added either neat or diluted up to 200-fold and run on 384-well plates in
quadruplicate. Pf and Pv assays were run separately using previously published primers and
probes [55] at a final primer-probe concentration of 0.8 μM and 0.4 μM, respectively. Human
beta-actin primers and probe were included in each assay (both at a final concentration of
0.1 μM) as an endogenous target for quality control [56,57]. TaqMan Gene Expression Master
Mix was added as a source of polymerase and other real-time PCR reaction components
(Thermofisher, Massachusetts, US). Cycling parameters comprised 50˚C for 2 minutes, 95˚C
for 10 minutes, and 50×; 95˚C for 15 seconds, followed by 58˚C for 1 minute for Pf or 60˚C for
1 minute for Pv. The mean cycle threshold value was used if samples had >1 replicate positive.
Those with a cycle threshold standard deviation >0.8 between replicates were repeated, or the
outlier excluded if >2 replicates were positive.
Reticulocyte assays
Samples. Two patient cohorts were included in the reticulocyte evaluations. In the Indo-
nesian splenectomy cohort, peripheral blood, sliced-spleen blood, and paraffinised spleen tis-
sue blocks were used for reticulocyte evaluations. Reticulocyte results from the Indonesian
infected spleens provided impetus to examine a second cohort of uninfected control spleens in
Paris, France.
In the second cohort, hospital patients undergoing spleno-pancreatectomy for any reason
were enrolled between December 2017 and December 2020 as part of ongoing splenic physiol-
ogy studies in Paris, an area non-endemic for malaria. Patients received normal medical and
surgical care according to hospital protocols. Clinical data were collected including age, sex,
and surgical information. Spleens were collected on the day of surgery according to published
protocols [28]. The splenic artery was cannulated within 90 minutes of the surgical procedure.
Spleens were macroscopically and microscopically normal. Spleens were flushed with 100 to
500 mL of Krebs-albumin solution (25 mmol NaHCO3, 118 mmol NaCl, 4.7 mmol KCl, 1.2
mmol MgSO47H2O, 1.2 mmol NaH2PO4, CaCl2, 7 mmol glucose, and 5 gr Albumax-II, in 1 L
of water) using a 3-mm catheter inserted into the artery and ligated tightly to allow flushing at
physiological pressure, with several wash fractions collected consecutively from the vein into
5-mL lithium-heparin blood tubes or 50-mL polyethylene tubes. Transfusion-related perfusion
experiments were conducted thereafter as reported [58].
Magnetic enrichment. Heparin-anticoagulated peripheral blood and sliced-spleen blood
from Indonesian patients were magnetically enriched for reticulocytes within 24 hours of sur-
gery. First, blood samples were centrifuged and had plasma/supernatant removed, then RBC
pellets were resuspended in equal volumes of cold MACS buffer (1:20 ratio of MACS bovine-
serum-albumin stock and autoMACS Rinsing Solution). Twelve μL of anti-CD71 MicroBeads
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were added per mL of reconstituted blood, mixed, then incubated for 15 minutes at 4˚C.
Labelled blood samples were centrifuged, supernatants discarded, and pellets washed and
resuspended in equal volumes of cold MACS buffer. Labelled samples were kept cold until fur-
ther use. A small volume was aliquoted for CD71 phenotyping by flow cytometry. MS Col-
umns connected to 30 μm Pre-Separation Filters were attached to a magnetic octoMACS
Separator. Columns were hydrated with cold MACS buffer, then carefully loaded with 2 mL of
labelled sample per column. Cells labelled with anti-CD71 MicroBeads were retained in the
columns, while non-labelled cells collected into individual falcon tubes. Once sample flow
stopped, 1 mL of cold MACS buffer was added to wash each filter/column. Wash buffer was
allowed to completely elute, then pre-separation filters were removed and columns were
washed again twice with cold MACS buffer. To collect retained cells, columns were removed
from the magnet and placed onto new falcon tubes. Cells were eluted by adding 1 mL of cold
MACS buffer and the columns drained manually with supplied plungers. The multiple
enriched suspensions were pooled into 2 tubes labelled as peripheral blood or sliced-spleen
blood, then the total number of cells in each tube counted using a Neubauer chamber. All
reagents and consumables were purchased from Miltenyi Biotec (Bergisch Gladbach,
Germany).
Flow cytometry. In the Indonesian cohort, pre-enriched (5 μL) and enriched (200,000
cells) suspensions from peripheral blood and sliced-spleen blood samples were stained with a
3-colour flow cytometry panel consisting of anti-CD45 (clone HI30) conjugated to Alexa
Fluor 488, anti-CD71 (clone CY1G4) conjugated to phycoerythrin, and the fluorescent nucleic
acid dye SYTO61. Isotype controls comprised anti-IgG2a conjugated to phycoerythrin instead
of anti-CD71. Stains were incubated for 20 minutes at RT in the dark, then at least 150,000
events acquired on a BD Accuri C6 flow cytometer with CFlow Sampler software (BD Biosci-
ences, Australia). All antibodies were purchased from BioLegend (San Diego, California) and
SYTO61 from Thermofisher (Massachusetts, US).
In the French cohort, spleen fractions were centrifuged and 2 μL of each pellet resuspended
in 1 mL of 1% Albumax-II/phosphate-buffered saline (PBS) (Thermofisher, Massachusetts,
US). Suspensions were stained with anti-CD45 (clone HI30) conjugated to phycoerythrin-cya-
nine-7 and anti-CD71 (clone CY1G4) conjugated to allophycocyanin (both from BioLegend,
San Diego, California) for 20 minutes at 4˚C. Samples were washed, then resuspended in
diluted BD Retic-Count (thiazole orange) and incubated in the dark for 1 hour at RT. At least
150,000 events were acquired on a BD Accuri C6 flow cytometer with CFlow Sampler
software.
CD71 IHC. FFPE were sliced to 5 μm in thickness and layered onto treated microscope
slides. Sections underwent deparaffinisation, rehydration, and immunohistochemical staining
using an automated Leica BOND-III platform (Leica Biosystems, Wetzlar, Germany) with a
rabbit polyclonal anti-CD71 transferrin receptor primary antibody (Abcam, Cambridge,
United Kingdom), followed by secondary detection with N-Histofine simple stain MAX PO
(Nichirei Biosciences, Tokyo, Japan) and a hematoxylin counterstain. A conservative estimate
of the number of CD71+ immature reticulocytes was determined by a research microscopist in
the different spleen zones, presented as a percentage of RBCs (calculations were made as per
parasitaemia calculations). CD71+ immature reticulocytes in the sinus lumen were categorised
into non-adherent cells and those that appeared to be adhering to endothelial cells lining the
sinus lumen. To confirm their appearance in the spleen sections, reticulocyte-enriched blood
from a healthy donor was pelleted, fixed, embedded in paraffin, and stained with CD71, all fol-
lowing identical protocols for preparation of spleen tissue. Immature reticulocytes were identi-
fied as CD71+ cells of variable size without large nuclear staining and with refractory
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properties similar to RBCs. A minimum of 1,000 RBCs in the red-pulp zones and 150 RBCs in
the white-pulp zones were counted for each spleen section.
Deformability. An in vitro assay for the measurement of reticulocyte deformability was
performed on a subset of ACD-anticoagulated peripheral blood and sliced-spleen blood from
Indonesian patients within 24 hours of surgery. WBC depletion was performed prior to micro-
sphiltration using Plasmodipur filters as per manufacturer’s instructions (EuroProxima, Arn-
hem, the Netherlands). Microsphere tips that mimicked mechanical filtration in the spleen
were prepared in Australia as previously described [59], dried overnight in a vacuum compart-
ment, then transported at RT to Papua. Tips were stored at RT in sealed desiccated bags and
rehydrated with 1% Albumax-II/PBS for experiments. Prior to commencing the study, dehy-
dration and rehydration of tips were quality tested as described below and showed no differ-
ence in results compared to freshly prepared tips.
Fresh human RBCs were collected on the day of experiments for quality control of micro-
sphere tips. RBCs were washed with PBS and resuspended at 1% haematocrit in 1% Albumax-
II/PBS. Heated RBCs were prepared by incubating at 50˚C for 20 minutes. Heated and normal
RBCs were labelled with PKH-26 or PKH-67 Fluorescent Cell Linker kit for general cell mem-
brane labelling (Sigma Aldrich, Missouri, US) as described elsewhere [60]. PKH-labelled
heated and normal RBCs were added to WBC-free patient RBC samples, each making up 5%
of total RBCs. The resulting RBC suspensions were adjusted to 2% haematocrit using 1% Albu-
max-II/PBS and termed as splenic or peripheral upstream samples.
Microsphere tips were washed by perfusing with 2 mL of flow solution (1% Albumax-II/
PBS). A total of 600 μL of upstream sample was introduced upstream of the microsphere tip
and perfused with 6 mL of flow solution through the microbead layer. A constant flow rate of
60 mL/hour was maintained using an electric syringe pump. Each sample was run in triplicate
and the downstream samples retrieved into falcon tubes.
Quality control of microsphere tips was examined by comparing the retention rate of
heated and normal RBCs within the microbead layer. Labelling of heated RBCs with PKH-26
and normal RBCs with PKH-67 allowed these populations to be distinguished by fluorescence
(S2A Fig). Fifty microlitres of each upstream and downstream sample were diluted with
450 μL of flow solution and ran on a BD Accuri C6 flow cytometer with CFlow Sampler soft-
ware (BD Biosciences, Australia). Three hundred thousand events were collected per sample.
RBC retention rate was calculated using the following formula:
RBC retention rate ¼
½%upstream gate�   ½%downstream gate�
½%upstream gate�
� 100
Microsphere tips with a mean retention rate of>95% for heated RBCs and<5% for normal
RBCs were considered acceptable (S2B Fig).
Thin blood smears were prepared for each of the upstream and downstream samples and
stained with the New Methylene Blue Reticulocyte Stain (Sigma Aldrich, Missouri, US) as per
manufacturer’s instructions. Reticulocytes were counted by a research microscopist within 30
minutes of staining and expressed as a percentage of 3,000 RBCs. Reticulocyte retention rate
was calculated using the following formula and presented as the mean of 3 replicates:
Retic retention rate ¼
½%upstream retic count�   ½%downstream retic count�
½%upstream retic count�
� 100
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Parasite viability
Once established that non-phagocytosed IEs accumulated in the spleen (see Results), we deter-
mined by subculture whether IEs retrieved from the spleen tissue were viable.
Preparation and culture. The viability of Plasmodium IEs in the spleen and peripheral
blood was examined by testing their ability to grow ex vivo using previously described culture
methods [61,62]. Heparin-anticoagulated sliced-spleen blood and peripheral blood were used
for culture on the day of splenectomy. WBCs were removed from samples prior to culture
using Plasmodipur filters as per manufacturer’s instructions (EuroProxima, Arnhem, the
Netherlands). Each WBC-free sample was cultured in 2 separate flasks containing different
culture medium and at 1% haematocrit. One flask contained Pf culture media and comprised
RPMI 1640 medium supplemented with L-glutamine (2 mM), HEPES (25 mM), NaHCO3 (20
mM), gentamicin (40 mg/L), D-glucose (0.25%), and human serum (10%). The second flask
contained Pv culture media and comprised McCoy’s 5A medium (Thermofisher, Massachu-
setts, US) supplemented with L-glutamine (2 mM), HEPES (25 mM), NaHCO3 (20 mM), gen-
tamicin (40 mg/L), D-glucose (0.25%), and human serum (20%). Flasks were supplemented
with fresh human RBCs if peripheral or splenic RBCs from patients were insufficient for 1%
haematocrit culture conditions. Human serum and fresh RBCs were obtained from nonex-
posed donors with matching blood group. Flasks were incubated in a candle jar at 37˚C for up
to 3 weeks. Culture media was replaced every 48 hours, and fresh human RBCs were added if
parasitaemia exceeded 3%.
Monitoring by microscopy. Thick and thin blood smears were made for each flask on the
day of splenectomy, and again every 24 hours to monitor parasite growth. Slides were stained
daily with 3% Giemsa solution for 45 minutes at RT, then read by a research microscopist for
the presence of Plasmodium IEs using an Olympus CX31 microscope. Parasites were counted
in the thin smear per 5,000 RBCs, and the frequency of asexual stages (rings, trophozoites,
schizonts) were determined.
Statistics
Analyses and imaging were performed using GraphPad Prism 8 (GraphPad, California), ZEN
2 (Carl Zeiss, Germany) and FlowJo 10 (BD, Ashland). Minor adjustments to brightness/con-
trast were made to the entirety of some images which do not modify any original features. The
Wilcoxon matched-pairs signed rank test was applied to paired datasets. The Mann–Whitney
was used for between-group comparison on continuous variables and the chi-squared test for
categorical variables. Correlations were analysed using Spearman tests (spleen weights were
log-transformed). Two-sided p-values <0.05 were considered statistically significant.
Ethical approval
The studies were approved by the Human Research Ethics Committees of Gadjah Mada Uni-
versity, Eijkman Institute for Molecular Biology, Indonesia, Menzies School of Health
Research, Australia, and/or Ile-de-France II, France. In Indonesia, written informed consent
was obtained from the patient’s relatives during surgery and from each patient postoperatively.
Patient consent in the French cohort was obtained by the surgical team.
Results
High prevalence of Plasmodium infection in splenectomised patients
Twenty-two patients undergoing mostly trauma-related splenectomy were enrolled from 2015
to 2017 at RSUD Hospital in Timika (Table 1) which includes the addition of 7 patients to our
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Spleen Month Microscopy PCR
32, M, NP trauma 36.8 228 (N) 108 neg neg neg neg neg neg - UT - - - 19�
22, F, H trauma 36.4 490 (S) N/A HRP2+Pan+ neg neg neg neg Pf 3 days (DHP+PQ)f DHP+PQ - - - 12
39, M, NP trauma 36.4 142 (N) <37.0 neg neg neg Pf neg Pf e - UT - - - 11#
41, F, H splenomegaly 36.3 1,918 (SS) 4200 neg neg neg Pf neg Pf e - UT 1 PvJ N/A 20#^
16, M, H trauma N/A 690 (S) 320 neg neg Pf (a) US Pf Pf - IV-ART,
DHP
11 PvJ N/A 3^
41, M, H trauma 36.8 785 (S) 1,200 neg neg Pf (a) Pf Pf Pf - T 12 PfJ N/A 9^
20, M, L trauma 37.3 761 (S) 265 neg Pf (a) Pf (a) US Pf Pf 9.5 hours
(IV-ART)
IV-ART N/A N/A N/A 8




12, F, L trauma 36.0 704 (S) N/A neg Pf (a) Pf (a) Pf N/A Pf - T N/A N/A N/A 14^
20, M, H trauma 36.3 658 (S) 269 HRP2+Pan+ Pf (a,g) Pf (a,g) Pf Pf Pf <1 month (DHP
+PQ)g
DHP+PQ 2–4 PvJ N/A 7^
15, M, L trauma 36.2 335 (S) 190 HRP2+Pan+ Pf (a,g) Pf (a,g) Pf Pf Pf 3 days (DHP+PQ)f DHP+PQ 2 PfJ N/A 5^
30, M, NP trauma 36.8 438 (S) 164 HRP2+Pan+ Pf (a) Pf (a) Pf Pf Pf - IV-ART,
DHP+PQ
8 PvJ N/A 10^
15, M, H trauma 36.6 358 (S) 282 HRP2+Pan+ Pf (a,g) Pf (a,g) Pf Pf Pf - T 2 neg Pf 17�^
40, M, NP trauma 36.0 263 (S) 360 HRP2+Pan+ Pf (a,g) Pf (a,g) Pf Pf Pf - T 1 PvJ N/A 15^
28, M, L trauma 36.2 454 (S) 616 neg neg neg N/A Mix Pf Pv Mix Pf
Pv
- T 2–3 PvJ N/A 21
16, F, H splenomegaly 36.9 1,250 (SS) 221 neg neg neg Pv Pv Pv - T 1 PvJ N/A 16^
46, M, L trauma 37.0 279 (S) 72.4 neg neg neg Pv Pv Pv - DHP+PQf 1 PvJ N/A 4�^
25, F, NP trauma 36.9 80 (N) <37.0 N/A neg neg Pv Pv Pv - UT N/A N/A N/A 22^
19, M, NP trauma 36.0 130 (N) <37.0 neg neg neg Pv Pv Pv - UT N/A N/A N/A 18�^
24, F, NP trauma 36.5 300 (S) 96.0 neg neg Pv (a) Pv Pm Pv - DHP+PQ 11 PvJ N/A 2^




2 neg Pv 6
36, M, H trauma 36.5 446 (S) 153 neg Pv (a) Pv (a,g) Pv Pv Pv - IV-ART 1 PvJ N/A 1^
aM, male; F, female.
bH, highland Papuan; L, lowland Papuan; NP, non-Papuan.
cN, normal (<250 g); S, splenomegaly (250–1,000 g); SS, severe splenomegaly (>1,000 g).
dParasites in blood smears were staged into: a, asexual stages; g, gametocytes.
ePositive by histology and by real-time PCR only.
f1-day PQ dose (Pf).
g14-day PQ dose (Pv or mix).
hDHP, dihydroartemisinin-piperaquine; IV-ART, intravenous artesunate; PQ, primaquine; T, unknown treatment; UT, untreated.
iRefer to the following patient IDs when referred to in text and figures.
jSymptomatic malaria.
Total plasma IgM concentrations 2 standard deviations (SD) greater than the population mean (327 [SD = 385] mg/dL, n = 54 Timika matched-controls tested in
parallel), a diagnostic criterion for hyperreactive malarial splenomegaly.
There were no differences in parameters assessed between those who did or did not receive prior antimalarial treatment, therefore all patients were pooled for analysis.
Some patients received transfusion (�<60 minutes; #>60 minutes) prior to sample collection. Transfused bloods were Plasmodium-negative by microscopy.
^Patients in previously published cohort [29].
None of the patients were seropositive for human immunodeficiency virus, and none had fever (�37.5˚C) or other malaria symptoms at surgery.
Refer to S4 Table for patient-automated blood counts.
Patients 18 and 22 died within 1 week after splenectomy due to multiple traumatic injuries. Patient 8 was lost to follow-up.
Missing data–patient 3 body temperature (not recorded); patient 12 IgM data (heparin blood not available); patient 14 IgM and PCR data (peripheral blood not
available–peripheral RDT and slide results from hospital); patient 22 RDT result (not performed); PCR result at first recurrence (not tested for those with first
recurrence identified from health facility records).
IgM, immunoglobulin M; N/A, not available (missing); Pf, P. falciparum; Pm, P. malariae; Pv, P. vivax; RDT, Rapid Diagnostic Test; US, unreadable slide.
https://doi.org/10.1371/journal.pmed.1003632.t001
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first reported cohort [29]. The median age was 24.5 (range:12 to 46) years; 68.2% (15/22) were
male, and 68.2% (15/22) of Papuan ethnicity. Two patients underwent elective splenectomy,
20 were splenectomised following trauma. Five patients (22.7%) were treated for malaria in the
month before splenectomy, three within 3 days. There were no differences in parameters
assessed between those who did or did not receive prior antimalarial treatment, therefore all
patients were pooled for analysis. At splenectomy, patients were afebrile (�37.5˚C) and free of
other malaria-related symptoms. Splenomegaly was present in all but 3 patients. Macroscopic
features of spleens are shown in S3 Fig. The median spleen weight was 431g (range 80 to
1,918). Two patients with massive splenomegaly (patients #9 and #20) had total plasma IgM
concentrations 2 standard deviations (SD) greater than the population mean (327 [SD = 385]
mg/dL, n = 54 Timika matched-controls tested in parallel), a diagnostic criterion for HMS
[63].
In total, splenic Plasmodium infection was found in 21 of 22 (95.5%) splenectomised
patients (Table 2; Fig 1). Seven were infected with Pv, 13 with Pf, and 1 with a mixed Pf-Pv
infection. Spleen infection was more prevalent than blood infection, with peripheral parasitae-
mia positive by microscopy and/or PCR in 9 (40.9%) and 18 (81.8%), respectively. No individ-
ual had parasitaemia in peripheral blood but not in the spleen. One Pv and 2 Pf infections in
the spleen were undetectable by PCR in peripheral blood, as reported [29]. Of the 20 patients
surviving hospitalisation, 18 could be followed up post-discharge: 15 (83.3%) had at least 1 epi-
sode of recurrent parasitaemia within 12 months, 13 (72.2%) with symptomatic malaria (10
[55.5%] Pv; Table 1), in line with the increased risk of malaria following splenectomy in
Papua, Indonesia, greater for Pv than Pf [42].
In summary, we uncovered an overall prevalence of splenic Plasmodium infection of 95.5%
in patients undergoing (mostly post-trauma) splenectomy who are living in a malaria-endemic
area and with no malaria-related symptoms except for splenomegaly.
Intense splenic tropism of intact non-phagocytosed asexual IEs in the
spleen, greater in Pv than Pf
Validations. Non-phagocytosed IEs were validated as previously reported [29]. In brief,
IEs were quantified in peripheral blood and spleens on Giemsa-stained smears and tissue sec-
tions, respectively (Fig 1A and 1B, S4A and S4B Fig). In addition, an uninfected non-trauma
spleen in France perfused ex vivo with a mixture of Pf-IEs from culture showed that asexual
stages appeared similar to Pf and Pv-IEs in the in vivo spleen sections (Fig 1C) and was used
to validate the identification and staging of Pf-IEs between microscopists (S4C Fig). Pig-
mented phagocytes and phagocytosed parasites were observed on Giemsa-stained sections in
both Pv and Pf and were clearly distinguishable from non-phagocytosed intact IEs by the pres-
ence of dispersed dark pigment or engulfed parasites throughout the cytoplasm of larger more
intensely stained nucleated cells (Fig 1D). In PvAMA1-stained spleen sections (Fig 2A, S4D
Fig), PvAMA1+ IEs often appeared non-phagocytosed and were distinguishable from parasite
pigment. The non-phagocytosed PvAMA1+ IE-density in a typical spleen was similar to that of
Pv mature asexual stages on matching Giemsa-stained sections (0.39% versus 0.29%, respec-
tively, patient #1) [29], further confirming previous findings [29], and the accuracy of Giemsa-
based quantifications and the specificity of PvAMA1-based staining. As reported in Pf [29],
transmission electron micrographs taken from Pv-infected spleens also showed non-phagocy-
tosed IEs (Fig 2B). CD68-based staining confirmed that a substantial proportion of Pv and Pf-
IEs in the spleen were localised outside macrophages (Fig 2C), in line with previous results
[29] and CD68 stains in ex vivo Pf-perfused spleens [28]. Taken together, histology, immuno-
histochemistry, and electron microscopy robustly showed the presence and ability to
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17/22 (77.3) 5/7 (71.4) 11/13 (84.6) 1 (100) 0 0.49
(Continued)
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architecturally stage non-phagocytosed IEs in 15 of 17 spleens that could be analysed, opening
the way to the comparison of parasite and reticulocyte densities/localizations in spleens and in
peripheral blood.
Marked accumulation of asexual Pv and Pf in the spleen. Parasitaemia was determined
under the optical microscope by counting IEs on Giemsa-stained smears from peripheral
blood and tissue sections from spleens (see Methods for details). Results on the accumulation
of asexual-stage Pv and Pf IEs in the spleen have been reported previously [29]. Briefly, the
majority of non-phagocytosed IEs in infected spleens were asexual stages with a medians of
100% (IQR: 98.2% to 100%) in Pv and 84.2% (IQR: 58.7% to 90.9%) in Pf (Fig 3A). Sexual and
unclassifiable stages were present to a greater extent in Pf than Pv (Fig 3A). We observed
marked splenic tropism of asexual stages, whereby non-phagocytosed asexual parasitaemias
were significantly higher in spleen tissue compared to circulating peripheral blood for both Pv
(geometric mean 1.03% [95% CI: 0.480% to 2.19%] versus 0.0003% [95% CI: 0.0001% to
0.0006%], p = 0.03) and Pf (1.53% [95% CI: 0.678% to 3.43%] versus 0.007% [95% CI: 0.001%
to 0.044%], p = 0.02) [29]. All Pv infections had PvAMA1+ IEs present (S4D Fig) suggesting
the presence of mature asexual Pv stages. In Giemsa-stained spleen sections from 2 individuals
with Pv infection, 14.7% and 16.8% of asexual stages in the spleen were identified as schizonts,
while the remainder were asexual rings and trophozoites. These proportions are consistent
with the upper-end duration in which Pv rings/trophozoites (42 to 45.6 hours) and schizonts
(2.4 to 6 hours) exist in ex vivo Pv studies [64,65] when expressed as a percentage of the
48-hour lifecycle (88% to 95% rings/trophozoites and 5% to 12% schizonts, respectively). In Pf,
the median proportion of rings/trophozoites and schizonts in the spleen were 90% (IQR: 67.3
to 100) and 10% (IQR: 0 to 32.7), respectively [29]. All asexual stages found in peripheral circu-
lation were rings/trophozoites in Pv and rings only in Pf.
The bulk of asexual Pv biomass is in the spleen. Splenic and peripheral parasite bio-
masses were estimated based on spleen weight and total blood volume, respectively (see Meth-
ods for details). We have previously reported [29] that in Pv-infected individuals, a median of
2.74 × 109 (95% CI: 0.26 × 109 to 25.6 × 109) non-phagocytosed asexual Pv IEs were estimated
to be in the spleen, significantly higher than the 0.04 × 109 Pv-IEs (95% CI: 0.03 × 109 to




























11/18 (61.1) 5/5 (100) 5/11 (45.5) 1 (100) 0 0.043
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3/18 (16.7) 0 3/11 (27.3) 0 0 0.51
IQR, interquartile range; RDT, rapid diagnostic test.
�Continuous variables were compared using the Mann–Whitney test, and categorical variables using the chi-squared
test or Fisher exact test. P value <0.05 considered statistically significant.
https://doi.org/10.1371/journal.pmed.1003632.t002
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Fig 1. Counting malaria parasites on Giemsa-stained spleen sections of human spleens. Tissue sections stained with Giemsa were analysed in P. vivax- and P.
falciparum-infected spleens at 400× magnification using a Carl Zeiss AxioScan Z1. Representative P. vivax-infected spleen sections are from patient #1 and P.
falciparum from patient #17, with staging key of non-phagocytosed P. vivax and P. falciparum shown below these panels (a, asexuals) (a, b). Tissue compartments
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in Pf were not significantly different in the spleen (median 8.56 × 109 IEs [95% CI: 2.18 × 109
to 28.9 × 109]) compared to circulating peripheral blood (0.35 × 109 IEs [95% CI:0 to
3.99 × 109], p = 0.10) [29]. Our conservative estimates of asexual Pv biomass in the bone mar-
row suggest that this tissue does not appear to be a major contributor to total-body Pv biomass
(median of 0.1% [IQR: 0.04% to 0.21%]; Fig 3B), at least for asexual-stage Pv. The spleen is the
predominant compartment for asexual Pv biomass (98.7% [IQR: 95.1% to 98.9%]), followed
by a small intravascular component (1.2% [IQR: 1% to 5.8%]; Fig 3B) where Pv transmission
stages are accessible to the vector.
Greater splenic tropism of asexual Pv than Pf. We have previously reported [29] that
splenic asexual Pv-IE density was 3,590 times (IQR: 2,600 to 4,130) higher than circulating in
peripheral blood, significantly greater than the estimated spleen-to-circulating blood density
ratio in Pf infections (median 289 [IQR: 33.9 to 918]; Fig 3C). Total biomass ratios in these
compartments indicated that splenic asexual Pv biomass was a median 81 times (IQR: 14 to
205) higher than circulating in peripheral blood, while the median spleen-to-circulating
peripheral blood biomass ratio in Pf was 12 (IQR: 0.5 to 25; Fig 3C). Although such ratios do
not include Pf-IEs sequestered within non-splenic blood vessels, approximately 10-fold higher
ratios observed in Pv suggest greater splenic tropism with infection by this species.
Culturable splenic asexual IEs are viable and are mostly in the red-pulp cords. To
assess the viability of IEs in human spleens, the ability of splenic Plasmodium to grow ex vivo
was examined by relative changes in asexual stage frequency in concordance with the known
parasite lifecycles. Growth of splenic parasites was observed in 8 of 12 Pf-infected individuals
(S1 Table), in line with previous findings [29], including an absence of growth from peripheral
blood (patient #9). No Pv growth/maturation was observed in spleen blood from the 5 Pv-
infected individuals with<0.1% parasitaemia, cultured without reticulocyte enrichment.
The localization of non-phagocytosed asexual IEs was categorised into 4 splenic zones. A
median of 77.2% (IQR: 15.9% to 38.8%) and 21.3% (IQR: 60.8% to 81.6%) of asexual Pv-IEs
were found in the red-pulp cords and sinus lumens, respectively (Fig 3D).
Taken together, asymptomatic Pv infection is characterised by intense log-scale accumula-
tion of intact asexual parasites in the spleen [29]. Splenic tropism was especially predominant
in Pv, with young and mature asexual stages proportional to their lifecycle in vivo highly sug-
gestive of an endosplenic Pv replication cycle.
Could the magnitude of Pv-IE accumulation in the spleen arise solely from
retention of peripherally produced parasites?
Our findings indicate an intrasplenic Pv reservoir 80-fold greater than the whole parasite pop-
ulation in circulation, and Pv parasite densities thousands of times higher in the spleen com-
pared to peripheral blood. We extend our previous calculations [29] to determine if the
magnitude of splenic tropism could be achieved from the retention of peripherally produced
Pv-IEs alone. Assuming an average adult blood volume of 4 litres, a splenic blood volume of 15
mL/100 g of spleen tissue (determined from ex vivo flushing experiments), and an initial input
of 0.0003% peripheral Pv parasitaemia (as observed in our cohort), a 280 g spleen (the median
weight of Pv-infected spleens in our cohort) containing 42 mL of blood (�21 mL of RBCs)
with 90% splenic retention of IEs would have a splenic parasitaemia of 0.026% before the next
were categorised into white-pulp non-circulatory spaces and perifollicular zones, and red-pulp sinus lumen and cords. An uninfected control human spleen was
perfused with P. falciparum lab strain cultures and had Giemsa-stained sections examined to validate the appearance of asexual-stage Plasmodium (c).
Phagocytosed parasites (a–c) and pigmented phagocytes (d) were observed in Giemsa-stained spleen sections from infected individuals with representative images
shown for each species.
https://doi.org/10.1371/journal.pmed.1003632.g001
PLOS MEDICINE An endosplenic Plasmodium vivax lifecycle in chronic malaria
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003632 May 26, 2021 19 / 35
Fig 2. Confirming the integrity of non-phagocytosed IEs by immunohistochemistry and electron microscopy. Antibodies against PvAMA1, a marker for P.
vivax merozoites/mature stages staining red, were tested on spleen sections from patient #1 (a) and others (S4D Fig) to confirm previous findings [29] on the
presence of mature P. vivax stages. Spleen tissue from patients in the cohort was also examined by transmission electron microscopy to identify non-
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phagocytosed malaria parasites (p) inside erythrocytes (i), with representative images in both P. vivax (patient #2) and P. falciparum (patients #5 and #17) (b). IEs
in the spleen were largely localised outside of macrophages (m) as illustrated in P. vivax- (patient #18) and P. falciparum-infected (patient #17) spleen sections
stained with macrophage marker CD68, including examples of phagocytosed IEs shown on the right (c). IE, infected erythrocyte; m, macrophages; p, parasites;
PvAMA1, Pv apical membrane antigen-1.
https://doi.org/10.1371/journal.pmed.1003632.g002
Fig 3. Splenic accumulation and distribution of non-phagocytosed IEs in cohort patients. Non-phagocytosed parasites in
peripheral blood and spleen sections were counted by microscopy using an Olympus CX31 microscope. Stages were
categorised into asexual, sexual, and unclassifiable for Pv (n = 6) and Pf (n = 9). In Pv and Pf, all individuals had asexual
stages present. Sexual stages were reported in 1 Pv- and 6 Pf-infected individuals, and unclassifiable stages reported in 2 Pv-
and 6 Pf-infected individuals, with the median distributions summarised as shown (a). As an additional comparator to the
spleen, Pv biomass in the bone marrow was conservatively estimated based on a previous human study comparing relative
Pv parasitaemia in the bone marrow to peripheral blood [20] (�). The median percentage of non-phagocytosed asexual Pv
biomass found in the spleen, peripheral blood, and bone marrow was calculated (b). The median estimated non-
phagocytosed spleen-to-peripheral asexual parasite density and biomass ratios were compared between 6 Pv and 7 Pf (c)
(^reported previously [29]). The median distribution of asexual Pv stages in the splenic architecture was categorised into
those found in the RP cords and sinus lumens, and WP non-circulatory spaces and perifollicular zones (d). Two individuals
had<0.3% of asexual Pv in WP non-circulatory spaces. In panels a and d, the sum of segments in each pie chart may not add
up to 100% due to medians in one of the groups being zero despite some individuals having values>0%. In panel c, medians,
interquartile ranges, and ranges are shown, compared using the Mann–Whitney test (p-value<0.05 considered significant).
IE, infected erythrocyte; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; RP, red-pulp; WP, white-pulp.
https://doi.org/10.1371/journal.pmed.1003632.g003
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lifecycle (86 times higher than the initial input in circulation). This is nearly 40 times lower
than the observed intrasplenic Pv parasitaemia of approximately 1% in our cohort. To accom-
modate ongoing replication within peripheral blood, we added a multiplication rate to the cal-
culation. The prevailing effective multiplication rate in chronic asymptomatic malaria is
considered to be 1 per 48-hour lifecycle after taking into account invasion efficiency and para-
site clearance. Even assuming a multiplication rate of 10 in peripheral blood (which is >50%
efficiency for Pv in 1 cycle) [66], 99% splenic retention of IEs, and zero destruction by splenic
macrophages or other intrasplenic processes, the resulting intrasplenic Pv parasitaemia of
0.28% is still far from the approximately 1% observed in our cohort. Taken together, the den-
sity and biomass of Pv in the spleen cannot be explained numerically by parasite replication
events in the circulation alone. One potential explanation for this discrepancy is the presence
of an endosplenic asexual Pv lifecycle, which we hypothesised would be supported by a splenic
reservoir of immature reticulocytes.
The human spleen is a pool for immature CD71+ reticulocytes that are
targeted by Pv for invasion
Reticulocytes in enriched peripheral and sliced-spleen blood were categorised into CD71 sub-
populations by flow cytometry (Fig 4A) in a subset of the patients splenectomised due to
trauma, all with asymptomatic Plasmodium infection (S2 Table). The percentage and number
of immature CD71 intermediate- and high-expressing reticulocytes were significantly higher
in sliced-spleen blood relative to matching peripheral blood (all p = 0.002; Fig 4B). In the 2 to
5 months following splenectomy, both the percentages (p = 0.002) and absolute numbers
(p< 0.05) of immature CD71 intermediate- and high-expressing reticulocytes in peripheral
blood were significantly higher compared to values measured on the day of splenectomy (Fig
4C).
To support flow cytometry findings, spleen sections from the same patients (S2 Table)
were stained with CD71 by IHC to directly visualise and count immature CD71+ reticulocytes
(Fig 4D, S2C Fig). Here, infected spleens had a median immature CD71+ reticulocyte concen-
tration of 2.4% of RBCs [IQR: 0.8% to 3.9%], 11 times higher than the median in matching
peripheral blood by flow cytometry (0.22% [IQR: 0.12% to 0.33%], p = 0.002; Fig 4D). To pro-
vide insight into potential mechanisms of splenic accumulation, a microsphiltration assay was
used to examine reticulocyte deformability. Reticulocytes in the spleen and post-splenectomy
peripheral blood were found to be more rigid compared to those in peripheral blood on the
day of splenectomy (p = 0.03 and p = 0.06, respectively; Fig 4E), suggesting biomechanical
retention upstream of interendothelial slits in the red-pulp may be a contributing mechanism
of splenic reticulocyte accumulation.
To confirm that the splenic reticulocyte reservoir was not only restricted to infected spleens,
reticulocytes were examined in uninfected control spleens by ex vivo flushing from 9 patients
undergoing elective spleno-pancreatectomy in France (S3 Table). Here, normalised immature
CD71+ reticulocyte counts determined by flow cytometry (S2D Fig) were significantly higher
in fractions representing splenic content in comparison to peripheral blood (Fig 4F, left). In 4
of the spleens where examination of CD71 subpopulations was performed, an enrichment of
CD71-negative, low-, intermediate-, and high-expressing reticulocytes was clearly apparent in
splenic effluents compared to peripheral blood (Fig 4F, right).
In summary, immature CD71+ reticulocytes, the target cells for Pv invasion, accumulate in
the human spleen physiologically and during infection. Following splenectomy, this cell popu-
lation is present at higher concentrations in peripheral blood. These findings suggest that retic-
ulocytes naturally accumulate in the human spleen.
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Colocalization of non-phagocytosed IEs and immature CD71+ reticulocytes
in specific splenic compartments suggest an endosplenic Pv lifecycle
The locations of non-phagocytosed IE stages and immature CD71+ reticulocytes in the splenic
microcirculatory compartments were characterised by histopathology. All asexual Pv develop-
mental stages were observed in the spleen (Fig 5). Immature CD71+ reticulocytes accumulated
in all splenic compartments compared to peripheral blood and were expectedly more concen-
trated in each of the compartments than any of the Plasmodium stages (Fig 5A, left). These
cells predominated in the red-pulp cords and sinus lumens in Pv-infected spleens (median of
46% and 42%, respectively; Fig 5B).
In Pv infection, rings/trophozoites predominated over other Pv stages in each of the splenic
compartments (Fig 5A). Overall, a median of 73% of Pv rings/trophozoites were observed in
the cords and 20% were in the sinus lumens (Fig 5B). As such nearly all splenic Pv rings/tro-
phozoites (93%) colocalised in the red-pulp with immature CD71+ reticulocytes (88% of which
were in the red pulp cords and sinus lumens). Pv schizonts in the spleen were found at lower
densities and were absent in peripheral blood (Fig 5A). Their distribution varied widely with
medians of 54% in the red-pulp cords and 46% in the PFZ (Fig 5B). The PFZ was the only
compartment found to contain the very few Pv gametocytes that were observed in the spleen
of a single individual (Fig 5A and 5B).
The opportunity to histologically evaluate an uninfected spleen in our Papuan cohort
revealed an apparent enrichment of immature CD71+ reticulocytes in the splenic sinus lumens
during Pv (26% in control versus 42% in Pv; Fig 5B). Closer examination of infected
CD71-stained spleen sections uncovered a considerable proportion of immature CD71+ retic-
ulocytes that were in close contact with and apparently adherent to endothelial cells lining the
luminal side of the sinuses (Fig 5C, left). Counting of apparently adherent versus non-adher-
ent reticulocytes in these spaces indicated that a significantly higher proportion of immature
CD71+ reticulocytes in the red-pulp were apparently adherent in the sinus lumens of Pv-
infected spleens (p = 0.02), while proportions of adherent and non-adherent sinus lumen retic-
ulocytes in Pf were generally similar (p = 0.64; Fig 5C, middle). Ratios of adherent-to-non-
adherent immature CD71+ reticulocytes showed twice as many apparently adherent cells in Pv
(IQR: 1.2 to 4.0), significantly higher than the 1:1 ratio in Pf (IQR: 1 to 1.3, p = 0.01; Fig 5C,
right).
Taken together, the accumulation and colocalization of all asexual-stage malaria parasites
and immature CD71+ reticulocytes in the splenic red-pulp in asymptomatic Pv infections is
strongly suggestive of an endosplenic asexual lifecycle, of greater magnitude in Pv. The greater
proportion of immature CD71+ reticulocytes apparently adhering in the sinus lumen in Pv
may reflect an additional population of target cells for invasion, statically located in the direct
path of merozoites released from rupturing Pv schizonts upstream in the cords and PFZ. Dif-
ferences in the splenic compartmentalization and numbers of schizonts and gametocytes
between Pv and Pf may reflect different pathophysiological mechanisms contributing to their
splenic retention and modes of pathogenesis/transmission.
Discussion
The swollen spleen of nonfebrile humans exposed to Plasmodium contains a substantial hid-
den biomass of intact IEs, with densities hundreds to thousands of times higher than in circu-
lating peripheral blood [29]. Expanding these analyses with additional experiments and
patients has uncovered strong evidence to support the existence of a cryptic endosplenic life-
cycle in asymptomatic Pv infections. Both immature CD71+ reticulocytes and asexual-stage Pv
were concentrated and colocalised predominantly in the splenic red-pulp, consistent with a
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Fig 4. Increased density of immature CD71+ reticulocytes in human spleens. Samples were magnetically enriched for reticulocytes (retics) and
phenotyped by CD71 FC (a). The median retic purity in enriched samples was 95.8% [IQR: 94.3%–98.5%] for PB and 56.8% [IQR: 53.4%–72.6%] for sliced-
spleen blood. Numbers as a percentage of CD71+ retics and per 105 or 106 RBCs were determined for CD71 low-, intermediate- and high-expressing retics in
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role for the human spleen in both reticulocyte maturation and Pv growth and replication. The
distinct distribution of schizonts and greater adherence of sinus lumen reticulocytes in Pv-
infected spleens, are consistent with recently described spleen-specific Pv cytoadherence
[67,68], and suggest Pv-specific adaptations to survive in this organ. Vivax malaria should be
considered predominantly an infection of the reticulocyte-rich spleen, with secondary involve-
ment of the intravascular compartment. While important for transmission and pathogenesis,
the circulating compartment is not the principal site for parasite biomass and parasite interac-
tions with cells mediating immune responses.
Our findings indicate an intrasplenic Pv pool 80-fold greater than the whole parasite popu-
lation in circulation. This substantial difference cannot be explained numerically by parasite
replication events in the circulation alone, with our deductive calculations (outlined in the
Results) indicating that splenic retention of 90% of Pv-IEs from circulation would achieve an
intrasplenic parasitaemia of 0.03%, 40 times lower than what we observed in our cohort. Even
adding a parasite multiplication rate in peripheral blood of 10 to the calculation, the resulting
intrasplenic Pv parasitaemia is still 4-fold lower than observed in vivo. Of note, this assumed
multiplication rate of 10 is likely an overestimate in light of our observation that a proportion
of retained Pv-IEs are phagocytosed. A cryptic asexual Pv lifecycle outside the peripheral blood
is therefore by far the most robust explanation of our observations.
Previous studies in animals [33–37] and humans [38] have suggested accumulation of total
reticulocytes in the spleen. Here, we show that the human spleen is a hitherto unrecognised
reservoir for highly immature CD71 intermediate- and high-expressing reticulocytes. Their
increase in peripheral blood for months after splenectomy provides further indication of their
retention in the human spleen. The greater rigidity of immature splenic reticulocytes was evi-
dent by the reduced deformability of splenic compared to circulating reticulocytes, and along
with their predominance in the splenic cords is consistent with a biomechanical component to
their retention in the spleen. Immature reticulocytes also have adhesive capacity in vitro [30],
and their apparent adherence to sinus lumen endothelial cells in our cohort suggests cytoadhe-
sion as an additional mechanism by which immature CD71+ reticulocytes accumulate in the
spleen. Further non-histological studies are warranted to confirm the apparent adherence of
reticulocytes in the sinus lumen. Our observations in uninfected controls also suggest that the
human spleen is a natural physiological niche for maturation of immature reticulocytes.
Human erythropoiesis occurs physiologically in the bone marrow but in contrast to murine
models [69,70], is extramedullary only in rare disorders [71,72]. Whether erythropoiesis
occurs in the malarial spleen remains unclear and was not specifically examined in this study.
Apart from the increased rigidity of late/segmenting Pv schizonts [73] (and probably very
early rings up to 3 hours post-invasion [31]), the majority of circulating Pv parasites are gener-
ally deformable [74,75] suggesting these stages are less likely to be retained in the spleen
PB and the spleen (b) (n = 10 pairs). In addition, CD71+ retic populations in PB several months after splenectomy (median post-splenectomy retic
enrichment purity of 84.0% [IQR: 71.9%–86.6%]) was compared to PB at surgery (n = 10 pairs), presented as a percentage of CD71+ retics and as absolute
counts per μL blood (calculated based on automated RBC counts that were available for PB) (c). CD71+ retics were visualised on spleen section by CD71
immunohistochemistry (patient #4 section shown) and counted based on guidelines derived from CD71 staining of a retic-enriched blood pellet (d). CD71+
retics concentrations in the spleen by immunohistochemistry was compared to CD71+ retic concentrations in PB determined by FC (n = 10 pairs) (d).
Peripheral and splenic retic deformability in 6 patients was determined by microsphiltration and presented as retention rates (e). In France, ex vivo flushing
of 9 uninfected control spleens were performed (f). For each of the first 5 spleens, a PB fraction was collected either from the basilic or splenic vein, followed
by 5–6 consecutive SW fractions from 350–500 mL of flushing buffer. With initial results indicating a trend towards higher proportions of immature retics
in the last SW fractions, the volume of flushing buffer was increased to 500–650 mL for each of the next 4 spleens, resulting in 8–9 SW fractions being
collected. Immature CD71+ retics were quantitated in each fraction by FC (see S2D Fig), normalised, and compared to PB (f, left). In the last 4 spleens, retics
were phenotyped into CD71 negative, low-, intermediate-, and high-expression (f, right). Paired datapoints are connected by lines. Bars in all panels
represent medians. Error bars in f are interquartile ranges. The Wilcoxon test was used for all statistical comparisons (�p< 0.05 considered statistically
significant). FC, flow cytometry; PB, peripheral blood; RBC, red blood cell; SW, spleen wash.
https://doi.org/10.1371/journal.pmed.1003632.g004
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Fig 5. Immature CD71+ reticulocytes (retics) and non-phagocytosed Pv-IEs colocalise in specific splenic compartments. The density and total biomass of
CD71+ retics and non-phagocytosed Pv developmental stages (n = 6) were determined in the red-pulp SL, cords, PFZ, and white-pulp NCS (a). Non-phagocytosed
Pv parasites were categorised into 3 groups (rings/trophozoites, schizonts, gametocytes), and a fourth group of those with unclassifiable stages. The cumulative
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biomechanically. The formation of Pv rosettes reduces their deformability and may provide a
physical shield against the cell-mediated immune response [73] while enhancing splenic accu-
mulation. However, structures resembling Pv rosettes have not been observed in tissues in
vivo and were not obvious in the fixed spleen samples in this study. Pv-infected reticulocytes
are known to cytoadhere in vitro to human splenic fibroblasts that are found in the red-pulp
cords [67,68,76], and such cytoadherence may explain the splenic retention of a large propor-
tion of Pv in our cohort. We speculate that a similar mechanism may be underlying the accu-
mulation of Pv schizonts in the PFZ of the fast circulation. The expression of VIR proteins on
the surface of Pv-IEs have been shown to facilitate binding to intercellular adhesion molecule-
1 [76,77] and may be linked to Pv cytoadherence in the spleen, yet the exact interactions
remain unclear and warrant further investigation.
Our findings on the splenic accumulation and colocalization of different asexual stages of
Pv and immature CD71+ reticulocytes raise fascinating hypotheses regarding the biology of an
endosplenic asexual Pv lifecycle. Firstly, the small proportion of schizonts (15% to 17%) rela-
tive to rings/trophozoites (85% to 100%) in Pv-infected spleens is in line with their short dura-
tion in the Pv lifecycle (2.4 to 6 hours), with schizonts estimated to represent 5% to 12% of the
48-hour Pv lifecycle [64,65]. Secondly, compared to the vasculature, reduced blood flow and
shear stress in the slow open circulation of the splenic cords plausibly offer a more suitable
environment for successful reticulocyte invasion, the exact compartment where we observed
46% of Pv schizonts and 73% of earlier stages colocalised with close to half of the immature
reticulocytes in the spleen. Segmenting schizonts biomechanically trapped at the cordal-side of
inter-endothelial slits will rupture and provide the opportunity for merozoites to rapidly
invade surrounding immature reticulocytes that are also trapped in the vicinity. In addition,
we speculate that the small merozoites may readily cross inter-endothelial slits and invade the
second line of reticulocytes cytoadhering in the sinus lumens just downstream from these slits.
Thus, the splenic red-pulp shapes a niche for Plasmodium development, with its dense popula-
tion of immature reticulocytes especially favourable for Pv [16,31]. That schizont-stage Pv
become more fragile after successfully traversing tight slits [74] is speculatively a favourable
adaptation that may accelerate rupture and increase the chance of invasion of adjacent cytoad-
hering static immature reticulocytes in the sinus lumens.
Thirdly, we speculate that the schizonts located in the fast-circulation PFZ may serve as a
second source of merozoites to invade both adherent and non-adherent immature reticulo-
cytes that accumulate downstream in the sinus lumens. A lower chance of closely interacting
with immune cells is an advantage of being in these compartments compared to the cords, but
with a faster flow rate similar to peripheral circulation, it is possible that invasion events are
less likely to be successful in these spaces despite an equal number of immature reticulocytes
being available as the cords. This would be supported by the disproportionally large number of
early asexual stages, representing successfully invaded reticulocytes, in the cords (73%) com-
pared to sinus lumens (20%). Reticulocytes infected in the sinus lumens will eventually exit the
spleen and circulate. We therefore hypothesise that maintaining a presence in the fast
distribution of CD71+ retics and Plasmodium developmental stages in the splenic architecture was calculated in individuals in whom intrasplenic parasites were
visualised (b, left). The distribution of CD71+ retics in an uninfected spleen is also shown (b, right). In the splenic SL, a large proportion of CD71+ retics were
apparently adherent to endothelial cells on the luminal side as observed by CD71 immunohistochemistry (c, left, representative image from Pv patient #4). The
number of those apparently adherent (adh) and non-adherent (non-adh) were expressed as a percentage of red-pulp CD71+ retics in Pv as well as Pf, and compared
as paired data (connected lines) using the Wilcoxon test (c, middle). The ratio of adherent-to-non-adherent CD71+ retics in the SL was compared between Pv and
Pf using the Mann–Whitney test (c, right). A p-value<0.05 was considered significant. Data in a, b (left), and c (right) are individual datapoints with median and
interquartile range. adh, adherent; NCS, non-circulatory space; non-adh, non-adherent; Pf, Plasmodium falciparum; PFZ, perifollicular zone; Pv, Plasmodium vivax;
RBC, red blood cell; SL, sinus lumen.
https://doi.org/10.1371/journal.pmed.1003632.g005
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circulation of the spleen may partly be an adaption to maintain transmission, whereby a pro-
portion of invaded reticulocytes are destined to circulate as gametocytes. Presence in compart-
ments of the fast circulation may also allow Pv to survive during periods of immune activation
or destabilised tolerance in the splenic cords. In settings such as acute infection, where the
immunotolerant conditions reflected in our cohort is not yet acquired or has been lost, a
greater proportion of Pv circulate. While these hypotheses remain speculative, our findings to
date are consistent with Pv having evolved multiple mechanisms to maximise their survival
and replication in the spleen.
Reports in humans [19–22] and findings in a splenectomised nonhuman primate model
[50] have shown that the bone marrow, also rich in the immature CD71+ reticulocytes [31],
and known to be a niche for Pf sexual stages [23,78,79], is recognised as an additional compart-
ment for asexual and sexual Pv accumulation. It was not possible to examine bone marrow in
our splenectomy cohort. Our conservative estimates based on a 1:1 ratio of bone marrow-to-
circulating parasitaemia in uncomplicated acute Pv [20] suggest that the bone marrow does
not appear to be a major contributor to total-body Pv biomass in asymptomatic infections, at
least for asexual stages. Findings in the splenectomised primate model implicate the bone mar-
row as an important space for Pv gametocyte development [50] which may explain the rarity
of these stages in spleens from our cohort. However, the degree to which asexual and sexual Pv
may additionally infect the bone marrow in asymptomatic infections remains unknown.
With the entire intraerythrocytic asexual Pv lifecycle likely taking place predominantly in
the spleen, our study provides a new framework to explore innate and adaptive immune
responses to Pv and Pf. Human studies on the role of the spleen in malaria immunity are
urgently needed to inform vaccine development. We hypothesise that immunotolerance to
Plasmodium is developed in the cords of the spleen, induced by sustained high antigen loads.
This is evidenced by a large number of pigmented phagocytes and non-phagocytosed IEs in
our cohort. We speculate that, in addition to phagocytosis of active parasites, a proportion of
the pigment engulfed by phagocytes may come from rupturing schizonts [80] and may also
represent remnants from past infections [81]. Nevertheless, the predominance of pigmented
phagocytes in all spleens and visualisation of phagocytosed parasites in both Pv and Pf infec-
tions provide direct in vivo evidence of a major concurrent host-protective role for the spleen
in asymptomatic human Plasmodium infection and direct in vivo evidence for the long-
hypothesised clearance of untreated parasites. These data complement previous observations
on the central role of the spleen in clearing parasites following treatment with antimalarials
[26], postmortem data from fatal Pf malaria series [23,25,27], the majority of which had
received antimalarial treatment prior to death, and the biomechanical retention and/or clear-
ance of treated [28] and untreated [44,59] IEs seen in Pf ex vivo spleen studies.
Our study has several limitations. We report parasitaemia findings in semi-immune indi-
viduals with chronic asymptomatic infection, the majority with enlarged spleens. Our study
also had a small sample size. These limit the interpretation and generalizability of our findings
and warrant larger studies including in acute symptomatic malaria. Splenic trauma or rupture
are rare during clinical malaria and performing splenic studies in untreated clinical disease
may require indirect, noninvasive evaluation. Recent positron emission tomography and mag-
netic resonance imaging in experimental human volunteer infection studies indicate greater
splenic tropism and metabolic activity in early Pv infection compared to Pf [82], suggesting
that splenic accumulation of Pv occurs even early in infection. Our cohort requiring splenec-
tomy may also not be representative of the wider population. The inability to maintain Pv in
continuous culture and its fastidious growth requirements limited our ability to detect Pv
growth and confirm viability of the intact non-phagocytosed splenic Pv-IEs. However, ex vivo
parasite maturation confirmed the viability of non-phagocytosed intrasplenic Pf, including
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instances of growth from splenic but not peripheral blood. Even in the most optimal circum-
stances (immediate processing directly from venepuncture), a significant proportion of Pv per-
ish under ex vivo conditions, thus requiring a higher initial parasitaemia (>0.1%) than found
in our spleen blood eluates to ensure enough parasites survive to enable accurate experimental
observations [83].
In conclusion, our findings provide a major contribution to the understanding of malaria
biology and pathology. The spleen sustains a very large biomass of non-phagocytosed asexual
Pv parasites, concurrent with the increased availability of immature CD71+ reticulocytes, both
colocalised in splenic environments where invasion-reinvasion events would form a cryptic
endosplenic lifecycle. Like Pf, quantifying circulating parasitaemia alone will significantly
underestimate total-body Pv biomass in asymptomatic infections. This hidden biomass is
likely a significant contributor to anaemia and challenges the assumptions underlying prevail-
ing mathematical models of malarial anaemia derived from circulating parasitaemia and the
proportions of uninfected-to-infected RBCs lost in chronic infections from both Plasmodium
species [84,85], particularly so for Pv. Cross-talk between different parasite species/stages and
immune cells are likely different in specific intrasplenic microenvironments compared to the
circulation, with architectural distributions suggesting Pv may have evolved multiple mecha-
nisms to maximise their survival and replication in the spleen.
Supporting information
S1 Fig. Spleen dissection and microscopist validations. Each spleen was weighed and
recorded to nearest gram (a), then sliced in half using sterile disposal blades (b). One half of
the spleen was sliced longitudinally (c) and used for downstream experiments, while the sec-
ond half was processed into paraffinised spleen tissue blocks. A subset of n = 6 Giemsa-stained
spleens were read by 2 expert microscopists to validate non-phagocytosed IE counts, including
the ability to distinguish into the different splenic architectural zones and parasite stages (d).
Each reader examined spleen sections from different spleen biopsies in the same patient. IE,
infected erythrocyte; RBC, red blood cell.
(TIF)
S2 Fig. Reticulocytes in the spleen and in peripheral blood. Heated and normal RBCs were
used for quality control of microsphere tips and gated as shown (a). Retention rates
(mean ± standard error) of>95% and<5% for heated and normal RBCs, respectively, satisfied
minimum requirements (b). Immature CD71+ reticulocytes (retics) in P. falciparum- and P.
vivax-infected spleens were stained by immunohistochemistry with antibodies against the
CD71 transferrin receptor; additional examples of retics are shown (c). A 3-colour flow cytom-
etry stain was used to quantitate retics in SW obtained from the flushing of normal spleens in
France, identified as CD45−thiazole-orange+ cells, with or without CD71 expression (d). A
3-colour flow cytometry panel was used to phenotype retics in the Indonesian cohort, identi-
fied as CD45−SYTO61+ cells with or without CD71 (e). Numbers per thousand RBCs were
determined for total, immature CD71+ and mature CD71− retics in PB and sliced SB samples
(n = 10 pairs, Wilcoxon test, f). Bars represent medians. FS, forward scatter; PB, peripheral
blood; RBC, red blood cell; SB, spleen blood; SW, spleen wash; TO, thiazole-orange.
(TIF)
S3 Fig. Images of spleens. Each patient’s spleen was photographed for macroscopic records.
Images not available for patient #13. Spleen weights presented in grams.
(PDF)
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S4 Fig. Malaria parasites in spleen sections and microscopy validations. Representative
images of Giemsa-stained spleen sections from P. vivax- (a, patient #1) and P. falciparum-
infected spleens (b, patient #20) showing non-phagocytosed IEs (red arrowhead), pigmented
phagocytes (green arrowheads) in the cords and sinus lumen. Giemsa-stained sections from
the ex vivo perfused spleen (Fig 1C) were read by 2 expert microscopists (c). Reading included
5 fields of RP comprising cords and sinus lumen (sl), and 5 fields of WP, with the resulting
counts in close agreement (<15% variation from the mean of readings). Additional images
from immunohistochemical stains using antibodies against PvAMA1 were taken from several
P. vivax-infected spleen sections showing merozoites/mature stages staining red (d). IE,
infected erythrocyte; PvAMA1, Pv apical membrane antigen-1; RP, red-pulp; sl, sinus lumen;
WP, white-pulp.
(TIF)
S1 Table. Ex vivo growth of peripheral and splenic Plasmodium parasites.
(DOCX)
S2 Table. Baseline characteristics of patients with reticulocytes evaluated by flow cytome-
try.
(DOCX)
S3 Table. Baseline characteristics of n = 9 spleno-pancreatectomy patients in France.
(DOCX)
S4 Table. Full blood counts at surgery.
(DOCX)
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